RSS Feeds
Search

Deals review

Nastech to reacquire intranasal Apomorphine product licenses from Pharmacia

In order to access this content you must be logged in and have a subscription to Pharmalicensing Intelligence.

Pharmalicensing Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.

Subscribe now for instant access to the benefits Pharmalicensing Intelligence has to offer. Find out more.

Related deals

Nastech reacquires apomorphine rights

Nastech plans efficacy studies of impotency drug apomorphine

Nastech and Pharmacia in Worldwide Agreement

Nastech Receives $2.0 Million Apomorphine Payment

Nastech licenses European rights to intranasal morphine

Nastechs treatment for motion sickness, intranasal Scopolamine performs well in clinical studies

Nastech licenses patents to siRNA technology

Cytogen to reacquire marketing rights

Nastech Acquires Exclusive Worldwide Rights to PYY Patent Applications for Nasal Administration From Thiakis

Pharmacia licenses LeadScope Enterprise

Related categories

Therapeutic target
Genito-urinary
Gender related medicine female
Gynecological disorder (other)
Industry sector
Drug delivery
Nasal
Pharmaceutical
Prescription

More deals

Latest deals

AspenTech Expands Direct Presence in Russia and CIS; Ends Reseller Agreement with Hyperion Systems Engineering
POSITRON ANNOUNCES STRATEGIC ALLIANCE WITH COVIDIEN; TO DEVELOP INNOVATIVE DISTRIBUTION MODEL
Misonix Announces New GPO Agreement With First Choice Cooperative
Oridion signs new distributor agreement with IMI expanding its presence in the Japanese Market
Cardica and Intuitive Surgical Enter Into License Agreement

Most viewed deals

Recommended acquisition of Acambis plc ("Acambis") by Sanofi Pasteur Holding ("Sanofi Pasteur") by way of scheme of arrangement Posting of Scheme Document
Bayer CropScience and Janssen PMP conclude research agreement:
Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded to Singapore and Vietnam
Merck & Co., Inc., Medarex, Inc. and Massachusetts Biologic Laboratories Sign Exclusive Licensing Agreement for Investigational Monoclonal Antibody Combination for Clostridium Difficile Infection
Bayer CropScience and Evogene to extend collaboration for rice yield improvement

By month

September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2010 Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us